Back to CGEM

UBS Group AG → CGEM

UBS Group AG CGEM Position History

Cullinan Therapeutics, Inc. • Healthcare

Quarters held
15
Latest value
$138
Q3 2026
Peak value
$2.4M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$690K
Q3 2025$426K
Q4 2025$1.3M
Q4 2025$739K
Q4 2025$819K
Q1 2026$1.7M
Q1 2026$1.1M
Q2 2026$2M
Q2 2026$2.4M
Q2 2026$60K
Q2 2026$15K
Q3 2026$1.7M
Q3 2026$1.6M
Q3 2026$219K
Q3 2026$138

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1389——
Q3 2026$219K14.2K——
Q3 2026$1.6M104.2K——
Q3 2026$1.7M110.8K——
Q2 2026$15K821——
Q2 2026$60K3.3K——
Q2 2026$2.4M133.4K——
Q2 2026$2M111.1K——
Q1 2026$1.1M80.7K——
Q1 2026$1.7M121.7K——
Q4 2025$819K79.2K——
Q4 2025$739K71.4K——
Q4 2025$1.3M121.2K——
Q3 2025$426K71.8K——
Q3 2025$690K116.4K——

Other funds holding CGEM

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B